Sampre Nutritions allots 17.7 lakh shares to promoters via loan conversion

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Sampre Nutritions allotted 17,70,710 equity shares to promoters Brahma and Meera Gurbani
  • The allotment stems from the conversion of unsecured loans worth ₹7.44 crore
  • Issue price fixed at ₹42 per share, including a premium of ₹37 over face value
  • Brahma Gurbani’s stake rises to 7.48%, while Meera Gurbani’s increases to 3.47%
powered bylight_fuzz_icon
51892763

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions Limited approved the preferential allotment of 17,70,710 fully paid-up equity shares to its promoters, Brahma Gurbani and Meera Gurbani. The issuance, valued at ₹7.44 crore, results from the conversion of unsecured loans held by the allottees.

The Board of Directors authorized the transaction during a meeting held on September 25, 2026. The shares carry a face value of ₹5 each and were issued at a price of ₹42 per share, which includes a premium of ₹37. This move aligns with the special resolution passed by members on December 10, 2025, and received in-principle approval from BSE Limited in August 2026.

Allotment Details

The company disclosed that the allotment was executed on a preferential basis pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The total aggregate amount for the securities allotted is ₹7,43,69,820. The two investors involved are classified under the promoter and promoter group categories.

Particular Detail
Type of Securities Fully paid-up equity shares
Basis of Issuance Conversion of unsecured loan
Number of Shares 17,70,710
Issue Price ₹42 per share
Face Value ₹5 per share
Premium ₹37 per share
Total Amount ₹7,43,69,820
Number of Investors 2

Post-Allotment Shareholding Pattern

The conversion of debt into equity has altered the shareholding structure of the promoter entities. Brahma Gurbani, a promoter, saw his holding increase from 5.84% to 7.48% of the total share capital. Meera Gurbani, part of the promoter group, witnessed a marginal rise from 3.46% to 3.47%.

Allottee Category Pre-Issue Shares Pre-Issue % Shares Allotted Post-Issue Shares Post-Issue %
Brahma Gurbani Promoter 55,49,664 5.84% 16,93,880 72,43,544 7.48%
Meera Gurbani Promoter Group 32,83,048 3.46% 76,830 33,59,878 3.47%

What the Numbers Show

The data reveals a significant disparity in the volume of shares allotted to the two promoters despite their related status. Brahma Gurbani received 16,93,880 shares, constituting approximately 95.6% of the total allotment, while Meera Gurbani received only 76,830 shares. This indicates that the bulk of the unsecured loans converted into equity were held by Brahma Gurbani. Consequently, his stake expanded by 164 basis points, whereas Meera Gurbani’s stake grew by just 1 basis point, reflecting the proportional weight of their respective debt holdings against the company's equity base.

Historical Stock Returns for Sampre Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
-0.16%+0.50%+7.26%-69.96%-78.37%+53.81%

How will the conversion of ₹7.44 crore in unsecured debt to equity impact Sampre Nutritions' future interest expense obligations and cash flow stability?

What are the potential dilution effects on minority shareholders given the increased promoter concentration following this preferential allotment?

Does the significant disparity in share allotment between Brahma and Meera Gurbani signal a strategic consolidation of control or specific financial restructuring by the lead promoter?

Sampre Nutritions shareholders approve director reappointment and pay revision

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Shareholders approved adoption of audited financial statements with 99.99% support
  • Vishal Ratan Gurbani was reappointed as Director with unanimous promoter backing
  • Remuneration revision for Vishal Ratan Gurbani passed with 99.99% affirmative votes
  • Total voting turnout was 14.52% of outstanding equity shares
  • Statutory auditors reported no qualifications or adverse remarks
powered bylight_fuzz_icon
50054350

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions concluded its 35th Annual General Meeting on September 4, 2026, with shareholders approving key board resolutions via video conferencing.

The meeting, chaired by Managing Director Brahma Gurbani, commenced at 11:05 am in compliance with Ministry of Corporate Affairs and SEBI circulars. Members exercised their voting rights through remote e-voting facilitated by National Securities Depository Limited, which ran from September 1 to September 3, 2026.

Resolutions Passed

Shareholders approved three primary items during the proceedings:

  • Adoption of the Audited Financial Statements along with the Board of Directors and Auditors' reports.
  • Reappointment of Vishal Ratan Gurbani as a Director of the company.
  • Approval for a revision in the remuneration payable to Vishal Ratan Gurbani, who serves as Whole-Time Director and Vice President.

Voting Results

The consolidated scrutinizer's report indicates that all resolutions were passed with requisite majority. The total paid-up equity share capital available for e-voting was 95,008,913 shares. A total of 13,790,748 votes were polled, representing a 14.52% turnout of outstanding shares.

Resolution Votes in Favour Votes Against % in Favour
Adoption of Financial Statements 13,790,708 40 99.99%
Reappointment of Vishal Ratan Gurbani 13,790,708 40 99.99%
Revision in Remuneration for Vishal Ratan Gurbani 13,790,023 725 99.99%

Promoter and promoter group holdings stood at 13,337,503 shares. The promoters voted 13,335,852 shares in favour across all resolutions, reflecting near-total participation (99.99%) from this category. Public non-institutional shareholders held 81,671,410 shares but cast only 454,896 votes, indicating a low participation rate of 0.56% from this segment.

Governance and Audit Observations

The Chairman informed members that the Statutory Auditors' Report contained no qualifications, observations, comments, or other remarks. Consequently, the report was taken as read in accordance with the Companies Act, 2013. Similarly, the Secretarial Audit Report was taken as read after the Board's Report provided suitable explanations for the auditor's observations.

Akshita Surana & Associates were appointed as scrutinizers for both remote e-voting and voting conducted during the AGM. The facility for appointing proxies was not applicable due to the virtual nature of the meeting.

Attendees

Senior management and board members attended the meeting through VC/OAVM mode. Key attendees included:

Name Designation
Brahma Gurbani Managing Director
Vishal Ratan Gurbani Whole-Time Director and Vice President
Pradeep Narendra Poddar Non-Independent Director
Vanita Khatter Independent Director
Nagaraju Kanneganti Independent Director
Kireet Modi Independent Director
Krishnama Nupur Company Secretary
Vamshi Srinivas Vempati Chief Financial Officer

Members expressed appreciation for the company's performance and congratulated the Board on its growth achievements. No specific questions were raised during the speaker session.

Historical Stock Returns for Sampre Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
-0.16%+0.50%+7.26%-69.96%-78.37%+53.81%

How might the approved revision in Vishal Ratan Gurbani's remuneration impact Sampre Nutritions' operating margins and future profitability targets?

Given the low 0.56% participation rate from public non-institutional shareholders, what strategies is the board considering to improve minority shareholder engagement and voting turnout?

What specific growth initiatives or capital allocation plans are outlined in the newly adopted Audited Financial Statements for the upcoming fiscal year?

More News on Sampre Nutritions

1 Year Returns:-78.37%